pharma · Obesity, Overweight · Type 2 Diabetes
Eli Lilly and
Eli Lilly Co.
Eli Lilly and clinical programs — 58 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Lilly Corporate Center, Indianapolis, Indiana 46285, US
- Founded
- 1876
- Employees
- 55,860
- Programs
- 107
- Drugs
- 99
- Patents
- 0
Eli Lilly and projects
58 ClinicalTrials.gov programs sponsored by Eli Lilly and.
Eli Lilly and has 58 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
J5E-MC-JZXB
Eli Lilly Co.
Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms, Neoplasm Metastasis
1 trial -
J6M-MC-JSGD
Eli Lilly Co.
Neoplasm Metastasis, Breast Neoplasms
1 trial -
METFORMIN , DAPAGLIFLOZIN
Eli Lilly Co.
Type 2 Diabetes
1 trial -
Mirikizumab, Mirikizumab
Eli Lilly Co.
Ulcerative Colitis
1 trial -
N1T-MC-MALO
Eli Lilly Co.
Metabolic Dysfunction-Associated Steatotic Liver Disease
1 trial -
Orforglipron, Placebo to match LY3502970
Eli Lilly Co.
Obesity, Overweight
1 trial -
Placebo to match LY
Eli Lilly Co.
Overweight or Obesity, OSA (Obstructive Sleep Apnea)
1 trial -
Placebo to match LY, Muvalaplin
Eli Lilly Co.
Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
1 trial -
RAMUCIRUMAB, ERLOTINIB
Eli Lilly Co.
Metastatic Non-Small Cell Lung Cancer
1 trial -
Remternetug, Placebo to match LY
Eli Lilly Co.
Alzheimer’s Disease
1 trial
Frequently asked questions
How many clinical projects does Eli Lilly and have?
58 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.